Blocking of CD44-mediated adhesion to HA by Pep-1; no reduction in melanoma cell proliferation in vitro or growth in vivo; significant reduction in lung metastasis incidence and increased survival observed following a single intravenous injection of Pep-1. This evidence concerns the gene CD44 and melanoma.